Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Justin R Ortiz & Kathleen M Neuzil. (2019) Influenza vaccine programs for children in low- and middle-income countries: current status and way forward. Expert Review of Vaccines 18:7, pages 711-724.
Read now
Read now
M Imran Khan, Carlos Franco-Paredes, Sushant Sahastrabuddhe, R Leon Ochiai, Vittal Mogasale & Bradford D Gessner. (2017) Barriers to typhoid fever vaccine access in endemic countries. Research and Reports in Tropical Medicine 8, pages 37-44.
Read now
Read now
Ana Carvalho, Rebecca Van Roy & Jon Andrus. (2016) International Dengue Vaccine Communication and Advocacy: Challenges and Way Forward. Expert Review of Vaccines 15:4, pages 539-545.
Read now
Read now
Articles from other publishers (30)
Hannah C Moore, Jeffrey W Cannon, David C Kaslow, Theresa Lamagni, Asha C Bowen, Kate M Miller, Thomas Cherian, Jonathan Carapetis & Chris Van Beneden. (2022) A Systematic Framework for Prioritizing Burden of Disease Data Required for Vaccine Development and Implementation: The Case for Group A Streptococcal Diseases. Clinical Infectious Diseases 75:7, pages 1245-1254.
Crossref
Crossref
Lois A. Privor-Dumm, Gregory A. Poland, Jane Barratt, David N. Durrheim, Maria Deloria Knoll, Prarthana Vasudevan, Mark Jit, Pablo E. Bonvehí & Paolo Bonanni. (2021) A global agenda for older adult immunization in the COVID-19 era: A roadmap for action. Vaccine 39:37, pages 5240-5250.
Crossref
Crossref
Jean-Louis Excler, Lois Privor-Dumm & Jerome H Kim. (2021) Supply and delivery of vaccines for global health. Current Opinion in Immunology 71, pages 13-20.
Crossref
Crossref
Morgane Donadel, Maria Susana Panero, Lynnette Ametewee & Abigail M. Shefer. (2021) National decision-making for the introduction of new vaccines: A systematic review, 2010–2020. Vaccine 39:14, pages 1897-1909.
Crossref
Crossref
Jacob Puliyel. 2021. Universalising Healthcare in India. Universalising Healthcare in India
217
237
.
M. Imran Khan, Saher Aijaz, Farzeen Fatma Syed & Linda Kaljee. (2020) An optimal typhoid conjugate vaccine coverage complemented with WASH is imperative for the control of antimicrobial resistance in Pakistan. Vaccine 38:45, pages 6969-6970.
Crossref
Crossref
Joseph S. Bresee, Kathryn E. Lafond, Margaret McCarron, Eduardo Azziz-Baumgartner, Susan Y. Chu, Malembe Ebama, Alan R. Hinman, Anonh Xeuatvongsa, Silvia Bino, Dominique Richardson, Rachael M. Porter, Ann Moen, Mark McKinlay, Gayane Sahakyan, Sonam Wangchuk, Pan Ruowen, Zhang Yongchao, Cai Linlin, Coulibaly Daouda, Olgha Tarkhan-Mouravi, Philip L. Gould, Phillip Muthoka, Gideon O. Emukule, Sandra S. Chaves, Marc-Alain Widdowson, Dinagul Otorbaeva, Viengphone Khanthamaly, Kristina Stavridis, Vladimir Mikic, Nicolae Furtuna, Dumitru Capmari, Burmaa Alexander, Erica Dueger, Mirkhamudin Kamolzoda, Joshua Mott, Afif Bin Salah, Marie Mazur, Alba Maria Ropero Alvarez, Sonja J. Olsen, Sara Mirza, Carmen Sofia Arriola, Jane Seward, Samantha Kluglein, Amanda F. Bolster, Nguyen Minh Hang, Jeffrey W. McFarland, Nga Ha Thu & Thoa Thi Minh Nguyen. (2019) The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships. Vaccine 37:35, pages 5089-5095.
Crossref
Crossref
Melissa Malhame, Edward Baker, Gian Gandhi, Andrew Jones, Philipp Kalpaxis, Robyn Iqbal, Yalda Momeni & Aurelia Nguyen. (2019) Shaping markets to benefit global health – A 15-year history and lessons learned from the pentavalent vaccine market. Vaccine: X 2, pages 100033.
Crossref
Crossref
Sonali Kochhar, Kathryn M. Edwards, Alba Maria Ropero Alvarez, Pedro L. Moro & Justin R. Ortiz. (2019) Introduction of new vaccines for immunization in pregnancy – Programmatic, regulatory, safety and ethical considerations. Vaccine 37:25, pages 3267-3277.
Crossref
Crossref
Geofrey Makenga, Stefano Bonoli, Emanuele Montomoli, Trent Carrier & Joachim Auerbach. (2019) Vaccine Production in Africa: A Feasible Business Model for Capacity Building and Sustainable New Vaccine Introduction. Frontiers in Public Health 7.
Crossref
Crossref
Leslie P Jamka, Kenneth W Simiyu, Adwoa D Bentsi-Enchill, Aziza J Mwisongo, Helen Matzger, Anthony A Marfin, Andrew J Pollard & Kathleen M Neuzil. (2019) Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives?. Clinical Infectious Diseases 68:Supplement_2, pages S171-S176.
Crossref
Crossref
Kathleen M Neuzil, Andrew J Pollard & Anthony A Marfin. (2019) Introduction of Typhoid Conjugate Vaccines in Africa and Asia. Clinical Infectious Diseases 68:Supplement_1, pages S27-S30.
Crossref
Crossref
M. Teresa Aguado, Jane Barratt, John R. Beard, Bonnie B. Blomberg, Wilbur H. Chen, Julian Hickling, Terri B. Hyde, Mark Jit, Rebecca Jones, Gregory A. Poland, Martin Friede & Justin R. Ortiz. (2018) Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22–23 March 2017. Vaccine 36:7, pages 921-931.
Crossref
Crossref
Idda Romore, Ritha J. A. Njau, Innocent Semali, Aziza Mwisongo, Antoinette Ba Nguz, Hassan Mshinda, Marcel Tanner & Salim Abdulla. (2016) Policy analysis for deciding on a malaria vaccine RTS,S in Tanzania. Malaria Journal 15:1.
Crossref
Crossref
Andreas Hasman & Douglas J Noble. (2016) Childhood immunisation in South Asia – overcoming the hurdles to progress. Perspectives in Public Health 136:5, pages 273-277.
Crossref
Crossref
Stephen Sosler, Judith Kallenberg & Hope L. Johnson. (2015) Gavi's balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes. Vaccine 33, pages A4-A5.
Crossref
Crossref
Marien González-Lorenzo, Alessandra Piatti, Liliana Coppola, Maria Gramegna, Vittorio Demicheli, Alessia Melegaro, Marcello Tirani, Elena Parmelli, Francesco Auxilia & Lorenzo Moja. (2015) Conceptual frameworks and key dimensions to support coverage decisions for vaccines. Vaccine 33:9, pages 1206-1217.
Crossref
Crossref
. (2014) Enhancing the Work of the Department of Health and Human Services National Vaccine Program in Global Immunization: Recommendations of the National Vaccine Advisory Committee. Public Health Reports 129:5_suppl3, pages 12-85.
Crossref
Crossref
Miguel Betancourt-Cravioto, Pablo Kuri-Morales, Jesús Felipe González-Roldán & Roberto Tapia-Conyer. (2014) Introducing a Dengue Vaccine to Mexico: Development of a System for Evidence-Based Public Policy Recommendations. PLoS Neglected Tropical Diseases 8:7, pages e3009.
Crossref
Crossref
Shabir A Madhi & Umesh D Parashar. (2014) 116E rotavirus vaccine development: a successful alliance. The Lancet 383:9935, pages 2106-2107.
Crossref
Crossref
Richard Mahoney. (2014) The introduction of new vaccines into developing countries. V: Will we lose a decade or more in the introduction of dengue vaccines to developing countries?. Vaccine 32:8, pages 904-908.
Crossref
Crossref
Deepak Bajracharya, M. Imran Khan, Alfred Pach, Parisha Shrestha, Nilesh Joshi, Shyam R. Upreti, Thomas Wierzba, Mahesh Puri, Sushant Sahastrabuddhe & R. Leon Ochiai. (2014) 25 Years after Vi Typhoid Vaccine Efficacy Study, Typhoid Affects Significant Number of Population in Nepal. PLoS ONE 9:1, pages e77974.
Crossref
Crossref
Patricia R. Blank, Matthias Schwenkglenks, Christelle Saint Sardos, Julien Patris & Thomas D. Szucs. (2013) Population access to new vaccines in European countries. Vaccine 31:27, pages 2862-2867.
Crossref
Crossref
Alan Brooks, Thomas A Smith, Don de Savigny & Christian Lengeler. (2012) Implementing new health interventions in developing countries: why do we lose a decade or more?. BMC Public Health 12:1.
Crossref
Crossref
A. Brooks & A. Ba-Nguz. (2012) Country planning for health interventions under development: lessons from the malaria vaccine decision-making framework and implications for other new interventions. Health Policy and Planning 27:suppl 2, pages ii50-ii61.
Crossref
Crossref
C. B. Wonodi, L. Privor-Dumm, M. Aina, A. M. Pate, R. Reis, P. Gadhoke & O. S. Levine. (2012) Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria. Health Policy and Planning 27:suppl 2, pages ii27-ii38.
Crossref
Crossref
H. E. D. Burchett, S. Mounier-Jack, U. K. Griffiths, R. Biellik, P. Ongolo-Zogo, E. Chavez, H. Sarma, J. Uddin, M. Konate, Y. Kitaw, M. Molla, S. Wakasiaka, L. Gilson & A. Mills. (2012) New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries. Health Policy and Planning 27:suppl 2, pages ii5-ii16.
Crossref
Crossref
Sai Kit Lam, Donald Burke, Maria Rosario Capeding, Chee Keong Chong, Laurent Coudeville, Jeremy Farrar, Duane Gubler, Sri Rezeki Hadinegoro, Jeffrey Hanna, Jean Lang, Han Lim Lee, Yee Sin Leo, Chan Quang Luong, Richard Mahoney, John Mcbride, Jorge Mendez-Galvan, Lee Ching Ng, Suchitra Nimmannitya, Eng Eong Ooi, Donald Shepard, Jaco Smit, Rémy Teyssou, Laurent Thomas, Joseph Torresi, Pedro Vasconcelos, Dewa Nyoman Wirawan & Sutee Yoksan. (2011) Preparing for introduction of a dengue vaccine: Recommendations from the 1st Dengue v2V Asia-Pacific Meeting. Vaccine 29:51, pages 9417-9422.
Crossref
Crossref
Rana Hajjeh. (2011)
Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent
Haemophilus influenzae
type b vaccine experience
. Philosophical Transactions of the Royal Society B: Biological Sciences 366:1579, pages 2827-2832.
Crossref
Crossref
Orin S Levine, David E Bloom, Thomas Cherian, Ciro de Quadros, Samba Sow, John Wecker, Philippe Duclos & Brian Greenwood. (2011) The future of immunisation policy, implementation, and financing. The Lancet 378:9789, pages 439-448.
Crossref
Crossref